UA99707C2 - Phenanthridine derivatives as bradykinin antagonists - Google Patents
Phenanthridine derivatives as bradykinin antagonistsInfo
- Publication number
- UA99707C2 UA99707C2 UAA200809433A UAA200809433A UA99707C2 UA 99707 C2 UA99707 C2 UA 99707C2 UA A200809433 A UAA200809433 A UA A200809433A UA A200809433 A UAA200809433 A UA A200809433A UA 99707 C2 UA99707 C2 UA 99707C2
- Authority
- UA
- Ukraine
- Prior art keywords
- phenanthridine derivatives
- bradykinin antagonists
- same
- derivatives
- processes
- Prior art date
Links
- 150000005053 phenanthridines Chemical class 0.000 title abstract 2
- 239000003152 bradykinin antagonist Substances 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008196 pharmacological composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0501169A HU230518B1 (hu) | 2005-12-20 | 2005-12-20 | Bradykinin B1 receptor szelektív antagonista hatással rendelkező új fenatridin származékok, eljárás előállításukra, és az ezeket tartalmazó gyógyszerkészítmények |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA99707C2 true UA99707C2 (en) | 2012-09-25 |
Family
ID=89986469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200809433A UA99707C2 (en) | 2005-12-20 | 2006-12-19 | Phenanthridine derivatives as bradykinin antagonists |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8034827B2 (ru) |
| EP (1) | EP1966142A2 (ru) |
| JP (1) | JP2009520013A (ru) |
| KR (1) | KR101027623B1 (ru) |
| CN (1) | CN101341125B (ru) |
| AU (1) | AU2006327896B2 (ru) |
| CA (1) | CA2632941C (ru) |
| EA (1) | EA015419B1 (ru) |
| GE (1) | GEP20115216B (ru) |
| HU (1) | HU230518B1 (ru) |
| IL (1) | IL191601A0 (ru) |
| MX (1) | MX2008008200A (ru) |
| NO (1) | NO20083201L (ru) |
| NZ (1) | NZ568864A (ru) |
| TW (1) | TW200837058A (ru) |
| UA (1) | UA99707C2 (ru) |
| WO (1) | WO2007072092A2 (ru) |
| ZA (1) | ZA200805295B (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0600810A3 (en) * | 2006-10-27 | 2008-09-29 | Richter Gedeon Nyrt | New sulfonamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them |
| HUP0600809A3 (en) * | 2006-10-27 | 2008-09-29 | Richter Gedeon Nyrt | New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them |
| HUP0600808A3 (en) * | 2006-10-27 | 2008-09-29 | Richter Gedeon Nyrt | New benzamide derivatives as bradykinin antagonists, process for their preparation and pharmaceutical compositions containing them |
| AU2007360523A1 (en) * | 2007-10-27 | 2009-04-30 | Richter Gedeon Nyrt. | New non-peptide derivatives as bradykinin B1 antagonists |
| CN102159077A (zh) * | 2008-08-21 | 2011-08-17 | 吉瑞工厂 | 用于治疗神经性疼痛的方法 |
| US20110190348A1 (en) * | 2008-08-21 | 2011-08-04 | Pradeep Banerjee | Methods for treating cns disorders |
| WO2021191838A1 (en) | 2020-03-26 | 2021-09-30 | Richter Gedeon Nyrt. | NAPHTHYRIDINE AND PYRIDO[3,4-c]PYRIDAZINE DERIVATIVES AS GABAA α5 RECEPTOR MODULATORS |
| HU231691B1 (hu) | 2021-09-29 | 2025-10-28 | Richter Gedeon Nyrt | GABAA ALFA5 receptor modulátor hatású biciklusos aminszármazékok |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2541280B1 (fr) * | 1983-01-13 | 1985-06-21 | Rhone Poulenc Sante | Nouveaux derives du 1h, 3h-pyrrolo (1,2c) thiazolecarboxamide-7, leur preparation et les medicaments qui les contiennent |
| GB9913079D0 (en) | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
| FR2822827B1 (fr) | 2001-03-28 | 2003-05-16 | Sanofi Synthelabo | Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant |
| WO2002099388A2 (en) | 2001-06-07 | 2002-12-12 | Merck & Co., Inc. | Benzodiazepine bradykinin antagonists |
| AU2003228825A1 (en) * | 2002-05-03 | 2003-11-17 | Elan Pharmaceuticals, Inc. | Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| US6894061B2 (en) * | 2002-12-04 | 2005-05-17 | Wyeth | Substituted dihydrophenanthridinesulfonamides |
| US20050020591A1 (en) * | 2002-12-13 | 2005-01-27 | Dai-Shi Su | 2-Quinoxalinone derivatives as bradykinin antagonists and novel compounds |
| US6908921B2 (en) | 2002-12-13 | 2005-06-21 | Merck & Co., Inc. | Quinoxalinone derivatives as bradykinin B1 antagonists |
| WO2005004810A2 (en) | 2003-07-02 | 2005-01-20 | Merck & Co., Inc. | Arylsulfonamide derivatives |
-
2005
- 2005-12-20 HU HU0501169A patent/HU230518B1/hu unknown
-
2006
- 2006-12-19 AU AU2006327896A patent/AU2006327896B2/en not_active Ceased
- 2006-12-19 NZ NZ568864A patent/NZ568864A/en not_active IP Right Cessation
- 2006-12-19 JP JP2008546648A patent/JP2009520013A/ja active Pending
- 2006-12-19 US US12/158,606 patent/US8034827B2/en not_active Expired - Fee Related
- 2006-12-19 KR KR1020087015459A patent/KR101027623B1/ko not_active Expired - Fee Related
- 2006-12-19 WO PCT/HU2006/000120 patent/WO2007072092A2/en not_active Ceased
- 2006-12-19 GE GEAP200610820A patent/GEP20115216B/en unknown
- 2006-12-19 UA UAA200809433A patent/UA99707C2/ru unknown
- 2006-12-19 MX MX2008008200A patent/MX2008008200A/es active IP Right Grant
- 2006-12-19 CN CN200680048197XA patent/CN101341125B/zh not_active Expired - Fee Related
- 2006-12-19 CA CA2632941A patent/CA2632941C/en not_active Expired - Fee Related
- 2006-12-19 EP EP06831519A patent/EP1966142A2/en not_active Withdrawn
- 2006-12-19 EA EA200801549A patent/EA015419B1/ru not_active IP Right Cessation
-
2007
- 2007-03-09 TW TW096108271A patent/TW200837058A/zh unknown
-
2008
- 2008-05-21 IL IL191601A patent/IL191601A0/en unknown
- 2008-06-18 ZA ZA200805295A patent/ZA200805295B/xx unknown
- 2008-07-18 NO NO20083201A patent/NO20083201L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006327896B2 (en) | 2012-05-31 |
| EA015419B1 (ru) | 2011-08-30 |
| WO2007072092A3 (en) | 2007-11-01 |
| AU2006327896A1 (en) | 2007-06-28 |
| WO2007072092A2 (en) | 2007-06-28 |
| MX2008008200A (es) | 2008-11-14 |
| US20090270411A1 (en) | 2009-10-29 |
| HUP0501169A2 (en) | 2007-09-28 |
| CN101341125B (zh) | 2012-10-10 |
| CA2632941A1 (en) | 2007-06-28 |
| KR20080076971A (ko) | 2008-08-20 |
| EA200801549A1 (ru) | 2008-10-30 |
| KR101027623B1 (ko) | 2011-04-06 |
| NZ568864A (en) | 2011-07-29 |
| WO2007072092A8 (en) | 2008-03-20 |
| CA2632941C (en) | 2012-05-08 |
| HUP0501169A3 (en) | 2008-03-28 |
| TW200837058A (en) | 2008-09-16 |
| EP1966142A2 (en) | 2008-09-10 |
| NO20083201L (no) | 2008-09-18 |
| US8034827B2 (en) | 2011-10-11 |
| GEP20115216B (en) | 2011-05-25 |
| HU0501169D0 (en) | 2006-02-28 |
| HU230518B1 (hu) | 2016-10-28 |
| CN101341125A (zh) | 2009-01-07 |
| ZA200805295B (en) | 2009-05-27 |
| JP2009520013A (ja) | 2009-05-21 |
| IL191601A0 (en) | 2008-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ577916A (en) | Cyclopamine analogs | |
| MX2007011023A (es) | 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3. | |
| CY1110209T1 (el) | Υποκατεστημενες ενωσεις βενζο(d)ισοξαζολ-3-υλ-αμινης σαν αναλγητικα | |
| TW200714604A (en) | Substituted heterocycles and the uses thereof | |
| TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
| EP2350129A4 (en) | PD1 Antagonist Compositions and Methods for their Use | |
| MY148076A (en) | New sulfonamide derivatives as bradykinin antagonists | |
| MX2009006706A (es) | Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos. | |
| GB0625648D0 (en) | Compounds | |
| MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
| UA92907C2 (ru) | Производные тетрагидроиндазолона | |
| TW200639173A (en) | Substituted pyrazolopyridines, compositions containing same, manufacturing process therefor and use thereof | |
| TW201129565A (en) | Tricyclic heterocyclic compounds, compositions and methods of use thereof | |
| TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
| MA32544B1 (fr) | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique | |
| UA83875C2 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
| NZ594186A (en) | Indole derivatives as anticancer agents | |
| TW200611904A (en) | Aza-bicyclononanes | |
| IL205696A0 (en) | Heterocyclic derivatives, compositions comprising the same and uses thereof | |
| MY148476A (en) | New benzamide derivatives as bradykinin antagonists | |
| MX2010009644A (es) | Derivados piridin-2-ilo como agentes inmunomoduladores. | |
| MX2010009927A (es) | Derivados de espiroindolinona. | |
| TW200738659A (en) | Novel compounds | |
| MY164998A (en) | Isoquinolinone derivatives as nk3 antagonists | |
| MY146671A (en) | Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents |